NVO - Medtronic raises outlook as diabetes segment outperforms in Q2
2023-11-21 07:45:31 ET
More on Medtronic
- Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
- Medtronic Stock Is Simply Too Cheap To Ignore
- Medtronic Faces Potential Decline Despite Financial Strength
- Medtronic Non-GAAP EPS of $1.25 beats by $0.07, revenue of $8B beats by $80M
- Medtronic blood pressure treatment cleared in U.S.
For further details see:
Medtronic raises outlook as diabetes segment outperforms in Q2